Clinical Trial Update: A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating omalizumab in chronic rhinosinusitis with nasal polyps has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Polyps
• Rhinosinusitis
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Nasal Polyps, Chronic Rhinosinusitis | Phase 3 | Status: COMPLETED | Results posted: 2020-03-23